The Use of Deliberate Practice in Simulation-Based Surgical Training for Open General and Subspeciality Surgery: A Systematic Review.

Simul HealthcOct 1, 2026 (epub)
Clinical ResearchGeneral Surgery

Dakshitha Praneeth Wickramasinghe, Jonathan Vincent

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluates the integration of deliberate practice (DP) in simulation-based surgical training (SBST) for open general and subspecialty surgery. Analyzing 22 studies, it found that DP-informed SBST generally improves surgical skills, although the correlation between the number of DP elements and learning outcomes was inconsistent. Most studies reported positive skill acquisition.

Key findings

  • 22 studies were included, primarily from North America and Europe.
  • Most studies reported improvements in surgical skills after DP-informed SBST.
  • Kirkpatrick levels 1 and 2 evaluations were the most common.
  • Variations in DP implementation limited direct comparison across studies.

Why it matters

Understanding the effectiveness of deliberate practice in surgical training can help enhance educational strategies, ultimately improving surgical proficiency and patient safety. Structured training approaches may lead to better skill acquisition among trainees.

Source

PubMed · PMID 41440926

Published in Simul Healthc. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in General Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.